This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q95846071
rdf:type
wikibase:Item
schema:description
article scientifique publié en 2020 wetenschappelijk artikel наукова стаття, опублікована 26 травня 2020 scientific article published on 26 May 2020 artículu científicu espublizáu en mayu de 2020
p:P577
wds:Q95846071-65FCD62B-A700-4CB8-9FD8-604324066CB9
wdt:P577
2020-05-26T00:00:00Z
p:P2093
wds:Q95846071-82327D6F-9839-4022-994C-B711122B9258
wdt:P2093
Ulrich A Walker
rdfs:label
Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab
skos:prefLabel
Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab
schema:name
Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab
p:P50
wds:Q95846071-343A5A17-0BF5-46BC-B21C-BA8C19B90415 wds:Q95846071-957E87F7-9655-496D-AC07-AE4F2BA7BCB5
wdt:P50
wd:Q95846069 wd:Q84068310
p:P1476
wds:Q95846071-2E5ECDDE-AE58-4C41-9330-CAABE66A6AD5
wdt:P1476
Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab
p:P31
wds:Q95846071-9352ED77-CD89-4A9F-9E9F-9BDA7BBF267E
wdt:P31
wd:Q13442814
p:P921
wds:Q95846071-7FFAC4A4-1AA4-4DFF-B4AF-DB4BA93A5646 wds:Q95846071-1E37D2DE-896B-4E59-8789-9A9E8C2F6851 wds:Q95846071-03A2FE0F-6DBD-4ACA-90B0-2E40DDBA6541
wdt:P921
wd:Q412323 wd:Q84263196 wd:Q1134583
p:P698
wds:Q95846071-71CDA343-4A29-489D-B2AB-88BF3F6242D7
wdtn:P698
n12:32458534
wdt:P698
32458534
p:P1433
wds:Q95846071-D552040D-34D8-4085-ADAA-037FFB12F8D8
wdt:P1433
wd:Q4797636
p:P356
wds:Q95846071-EBDAA916-2B54-4E30-BCCC-467693E2702D
wdtn:P356
n8:ART.41380
wdt:P356
10.1002/ART.41380
p:P932
wds:Q95846071-3B8B9384-1C99-4C1C-86E3-05EAC80E94AC
wdt:P932
7283641